Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 2/20 | 0.48 |
| ▸ | TYMP | P19971 | 10/20 | 0.45 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | GMPS | P49915 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.39 |
| ▸ | PI4KA | P42356 | 1/20 | 0.38 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.38 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.38 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.38 |
| ▸ | AHCY | P23526 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7072210 | 0.85 | ADORA1 (0.42) | ADORA1TYMPNT5EGMPSADORA3 | |
| SCHEMBL24836165 | 0.81 | TYMP (0.44) | TYMPNT5EADORA3 | |
| SCHEMBL29812366 | 0.76 | ADORA1 (0.44) | ADORA1TYMPNT5EADORA3ADORA2A | |
| SCHEMBL7065752 | 0.74 | TYMP (0.71) | ADORA1TYMPNT5EADORA3ADORA2A | |
| SCHEMBL7065756 | 0.74 | TYMP (0.71) | ADORA1TYMPNT5EADORA3ADORA2A | |
| SCHEMBL8610903 | 0.74 | ADORA1 (0.82) | ADORA1TYMPADORA3ADORA2ASLC28A1 | |
| SCHEMBL8610899 | 0.74 | ADORA1 (0.82) | ADORA1TYMPADORA3ADORA2ASLC28A1 | |
| SCHEMBL31484253 | 0.74 | ADORA1 (0.82) | ADORA1TYMPADORA3ADORA2ASLC28A1 | |
| SCHEMBL6271785 | 0.73 | NT5E (0.73) | ADORA1TYMPNT5E | |
| SCHEMBL3318862 | 0.73 | NT5E (0.73) | ADORA1TYMPNT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030204079-A1 | Process for producing 2', 3'-diethy substituted nucleoside derivatives | AJINOMOTO CO., INC (JP) | 2003-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204079-A1 | Process for producing 2', 3'-diethy substituted nucleoside derivatives | RNGTT, DOHH, NT5C3B | ADORA1 2863/4885TYMP 38/4885NT5E 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.